Dear Alexion

Discussion in 'Alexion' started by anonymous, Oct 8, 2019 at 9:50 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    You've lost 45% of your stock value over the last 5 years. You're now a sub $100 stock and aren't going anywhere anytime soon except down even more. Biosimilars are knocking on your door.

    Kanuma, an $8.4 billion dollar disaster that doesn't even earn enough money to pay for the interest on the loan you took out to buy that dud.

    Finding Soliris was akin to panning for gold and finding diamonds. It's not going to happen again.

    Please hurry up and sell so I can unload the rest of my remaining stock at a premium.
     

  2. anonymous

    anonymous Guest

    Sale is imminent, when the stock price drops below $90 the acquisition is a no brainer. Cost vs short and long term profit would make sense to any firm. The company streamlined its debt and overhead 2 years ago which was a tough call but much needed. And has since replaced it with even bigger debt and even larger overhead. If you don't agree with this statement, maybe you should go meet with the VP of Culture :)
     
  3. anonymous

    anonymous Guest

    Here comes UBC
     
  4. anonymous

    anonymous Guest

    Yes - here they will come with a way less expensive therapy - no infusion!!!
     
  5. anonymous

    anonymous Guest

    DREAM ON........
     
  6. anonymous

    anonymous Guest

    The place is a dump!
     
  7. anonymous

    anonymous Guest

    within 6 months Alexion will be sold, get out now.
     
  8. anonymous

    anonymous Guest

    Sure walk away from all of your stocks vesting at once. ‍♀️‍♀️
     
  9. anonymous

    anonymous Guest

    I agree...dump all the way...

    aint nobody buying $700,000 per patient drug to where competition has a better product and less expensive...has anybody not seen the fucking documentary on alexion being bashed for high cost of drugs recently...get a life alexion
     
  10. anonymous

    anonymous Guest

    You have been warned, layoffs are coming
     
  11. anonymous

    anonymous Guest

    And?
     
  12. anonymous

    anonymous Guest

     
  13. anonymous

    anonymous Guest

    You can not say you were not warned. More to come so do not believe them. There is a reason neurology has an unspoken ‘hiring freeze’.
     
  14. anonymous

    anonymous Guest


    You are an idiot...if it is going to be sold, why the fuck would you leave or sell stock?
     
  15. anonymous

    anonymous Guest

    they went on a hiring spree/expansion over a year ago. I’m surprised it’s lasted this long. People with 1 to 2 years will be cut. Meaning basically zero severance.
     
  16. anonymous

    anonymous Guest

    Exactly why they are redoing territories. Don’t kid yourself pal
     
  17. anonymous

    anonymous Guest

    So the high salary doesn’t make up for the drama? The small territory blows my mind. Obviously Im interviewing. A former MSL said it was horrible, But pretty much all rare dz companies suck these days. At least I’ll be miserable with a nice income vs the Standard market rate.
     
  18. anonymous

    anonymous Guest

    I heard medical people are leaving and no one is applying with qualifications. If medical people don’t want to peddle this they know we have no credibility and there are Issues with the leadership. A lot of us are interviewing. They have a seasoned team however they fail to understand the challenges they refuse to address. Giving us 30 marketing pieces won’t help when they charge 700k
     
  19. anonymous

    anonymous Guest

    This one is a special kind of screwed up shit. With competition and poor stock performance they are getting desperate and placing people on performance plans. This is how they will cut the sales force.
     
  20. anonymous

    anonymous Guest

    Ludwig sell this place now! We are all exhausted by this rollercoaster.